Blood pressure is a key bio marker in most clinical trials, offering important insight into a patient’s health and the performance of a drug candidate. As such, getting the most accurate reading is the essential. As part of a new consortium led by Tyndall National Institute, Ireland based dabl, is participating in a new project to develop health tech solutions based on emerging human-centric intelligent sensors. We explore how these smart wearables could disrupt blood management in clinical trials.

Also in this issue, we profile prominent technological developments enabling stronger and superior bone remodelling, find out what can be done to fix the medical industry’s software development deficit, and examine innovative alternatives to battery powered medical implants that use the human body to reduce the reliance on onboard batteries.

Plus, we explore the challenges of treating illness and injury in space, could 3D printing medical materials provide a solution for astronauts on long space missions, and ask if a single, harmonised auditing system for medical device manufacturing could grow into an extra regulatory layer with a global scope.

And, as always, we round up the latest news from the medical device industry, and get comment and analysis from GlobalData’s healthcare analysts.

Eloise McLennan, editor